Mustafa A S, Lundin K E, Meloen R H, Oftung F
Department of Microbiology, Faculty of Medicine, Kuwait University, Safat, Kuwait.
Clin Exp Immunol. 2000 Apr;120(1):85-92. doi: 10.1046/j.1365-2249.2000.01156.x.
We have previously demonstrated that the Mycobacterium leprae 18-kD heat shock protein (HSP18) is represented among the antigenic targets of human T cell responses induced by M. leprae immunization and that the peptide 38-50 serves as an immunodominant epitope recognized by CD4+ T cell clones. By using peripheral blood mononuclear cells and T cell lines from the same donor group, we have in this study shown that the M. leprae HSP18 and peptide 38-50 were recognized by memory T cells 8 years after immunization with M. leprae. The finding that M. bovis BCG-induced T cell lines responded to M. leprae HSP18, but not to the peptide 38-50, suggested the existence of additional T cell epitopes of a cross-reactive nature. Consistent with this, testing of the T cell lines for proliferative responses to the complete HSP18 molecule, truncated HSP18 (amino acid (aa) residues 38-148) and overlapping synthetic peptides, made it possible to identify two cross-reactive epitope regions defined by aa residues 1-38 and 41-55. While peptide 38-50-reactive T cell clones showed limited cross-reactivity by responding to M. leprae, M. avium and M. scrofulaceum, the T cell lines specific to the epitopes 1-38 and 41-55 were broadly cross-reactive, as demonstrated by their response to M. leprae, M. tuberculosis complex, M. avium and other mycobacteria. MHC restriction analysis of the HSP18-responding T cell lines showed that the epitopes 1-38 and 38-50 were presented by one of the two HLA-DR molecules expressed from self HLA-DRB1 genes, whereas the epitope 41-55 was recognized in the presence of autologous as well as HLA-DR and HLA-DQ mismatched allogeneic antigen-presenting cells. The results obtained in this study made it possible to identify cross-reactive T cell epitopes of the M. leprae HSP18, and provide an explanation for T cell recognition of this antigen in individuals infected with species of the M. tuberculosis complex or environmental mycobacteria.
我们之前已经证明,麻风分枝杆菌18-kD热休克蛋白(HSP18)是麻风分枝杆菌免疫诱导的人类T细胞反应的抗原靶点之一,并且肽段38-50作为被CD4+ T细胞克隆识别的免疫显性表位。在本研究中,我们使用来自同一供体组的外周血单核细胞和T细胞系,发现麻风分枝杆菌免疫8年后,记忆T细胞能够识别麻风分枝杆菌HSP18和肽段38-50。牛分枝杆菌卡介苗诱导的T细胞系对麻风分枝杆菌HSP18有反应,但对肽段38-50无反应,这表明存在其他具有交叉反应性质的T细胞表位。与此一致的是,检测T细胞系对完整HSP18分子、截短的HSP18(氨基酸(aa)残基38-148)和重叠合成肽的增殖反应,使得能够鉴定出由aa残基1-38和41-55定义的两个交叉反应表位区域。虽然对肽段38-50有反应的T细胞克隆对麻风分枝杆菌、鸟分枝杆菌和瘰疬分枝杆菌的反应显示出有限的交叉反应性,但对表位1-38和41-55特异的T细胞系具有广泛的交叉反应性,这通过它们对麻风分枝杆菌、结核分枝杆菌复合群、鸟分枝杆菌和其他分枝杆菌的反应得到证明。对HSP18反应性T细胞系的MHC限制性分析表明,表位1-38和38-50由自身HLA-DRB1基因表达的两个HLA-DR分子之一呈递,而表位41-55在自体以及HLA-DR和HLA-DQ错配的同种异体抗原呈递细胞存在的情况下被识别。本研究获得的结果使得能够鉴定麻风分枝杆菌HSP18的交叉反应性T细胞表位,并为结核分枝杆菌复合群或环境分枝杆菌感染个体中该抗原的T细胞识别提供了解释。